Company news

QTREX Quantum Ltd. news in 2022

QTREX Quantum Ltd.'s news releases, calls and decks from 2022, newest first.

View company

Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular

December 26, 2022

Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission

December 19, 2022

Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor

December 13, 2022

Inspira™ Technologies Reports Third Quarter 2022 Financial Results

November 22, 2022

InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System

November 9, 2022

Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies

September 6, 2022

Inspira™ Technologies Reports Second Quarter 2022 Financial Results

August 10, 2022

Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market

July 10, 2022

Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors

July 6, 2022

Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market

July 5, 2022

Inspira™ Technologies Announces First Quarter 2022 Financial Results

May 18, 2022

Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M

April 5, 2022

Inspira Technologies Releases Q4 & FY2021 Financial Results

March 30, 2022

Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD

February 2, 2022

Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals

January 30, 2022

Decks in 2022